Publications
Selected publications
- Patient-reported Outcomes and Quality of Life After Treatment of Choroidal Melanoma: A Comparison of Enucleation Versus Radiotherapy in 1596 Patients (Journal article - 2018)
- Predictors of anxiety and depression 2years following treatment in uveal melanoma survivors (Journal article - 2018)
- Two-year patient-reported outcomes following treatment of uveal melanoma (Journal article - 2016)
- How do patients with uveal melanoma experience and manage uncertainty? A qualitative study (Journal article - 2015)
- Phantom Eye Syndrome: Patient Experiences after Enucleation for Uveal Melanoma (Journal article - 2015)
- Prevalence, Temporal Course and Risk Factors for Phantom Eye Symptoms in Uveal Melanoma (Journal article - 2023)
- Predictors of emotional distress in uveal melanoma survivors: a systematic review (Journal article - 2023)
- 'I Don't Like Uncertainty, I Like to Know': How and why uveal melanoma patients consent to life expectancy prognostication (Journal article - 2022)
- Seven-Year Distress Trajectories in Uveal Melanoma Survivors (Journal article - 2023)
- Reflections on a Health Psychology Service for Patients with Uveal Melanoma: The Challenge of Psychological Screening and Intervention When Distress is 'Normal' (Journal article - 2019)
2025
Counseling Patients with Cancer
Damato, B. E., & Hope-Stone, L. (2025). Counseling Patients with Cancer. In Clinical Ophthalmic Oncology (pp. 151-159). Springer Nature Switzerland. doi:10.1007/978-3-031-75907-9_16
2024
Associations between empirically proportionate and disproportionate fears of cancer recurrence and anxiety and depression in uveal melanoma survivors: Five-year prospective study.
Brown, S. L., Hope-Stone, L., van der Voort, N., Hussain, R., Heimann, H., Coventry, W. L., & Cherry, M. G. (2024). Associations between empirically proportionate and disproportionate fears of cancer recurrence and anxiety and depression in uveal melanoma survivors: Five-year prospective study.. British journal of health psychology. doi:10.1111/bjhp.12719
2023
Prevalence, Temporal Course and Risk Factors for Phantom Eye Symptoms in Uveal Melanoma
Brown, S., Hope-Stone, L., Hussain, R., Heimann, H., van der Voort, N., & Cherry, M. (2023). Prevalence, Temporal Course and Risk Factors for Phantom Eye Symptoms in Uveal Melanoma. Eye. doi:10.1038/s41433-023-02756-w
Predictors of emotional distress in uveal melanoma survivors: a systematic review
Davies, C., Brown, S. L., Fisher, P., Hope-Stone, L., Fisher, D., Morgan, A., & Cherry, M. G. (2022). Predictors of emotional distress in uveal melanoma survivors: a systematic review. Eye. doi:10.1038/s41433-022-02193-1
Seven-Year Distress Trajectories in Uveal Melanoma Survivors
Brown, S. L., Hope-Stone, L., & Cherry, M. G. (2023). Seven-Year Distress Trajectories in Uveal Melanoma Survivors. HEALTH PSYCHOLOGY. doi:10.1037/hea0001270
2022
Therapists' experiences of remote working during the COVID-19 pandemic
Morgan, A., Davies, C., Olabi, Y., Hope-Stone, L., Cherry, M. G., & Fisher, P. (2022). Therapists' experiences of remote working during the COVID-19 pandemic. FRONTIERS IN PSYCHOLOGY, 13. doi:10.3389/fpsyg.2022.966021
'I Don't Like Uncertainty, I Like to Know': How and why uveal melanoma patients consent to life expectancy prognostication
Brown, S. L., Fisher, P. L., Morgan, A., Davies, C., Olabi, Y., Hope-Stone, L., . . . Cherry, M. G. (2022). 'I Don't Like Uncertainty, I Like to Know': How and why uveal melanoma patients consent to life expectancy prognostication. HEALTH EXPECTATIONS, 25(4), 1498-1507. doi:10.1111/hex.13490
Using a population mental health perspective in a psycho-oncology service for uveal melanoma survivors
Brown, S. L., Hope-Stone, L., & Cherry, M. G. (2022). Using a population mental health perspective in a psycho-oncology service for uveal melanoma survivors. Clinical Psychology Forum, 1(356), 50-57. doi:10.53841/bpscpf.2022.1.356.50
Using a population mental health perspective in a psycho-oncology service for uveal melanoma survivors
Brown, S. L., Hope-Stone, L., & Cherry, M. G. (2022). Using a population mental health perspective in a psycho-oncology service for uveal melanoma survivors. Clinical Psychology Forum, 2022(356), 50-57.
Is accurate routine cancer prognostication psychologically harmful? 5-year outcomes of life expectancy prognostication in uveal melanoma survivors
Brown, S. L., Fisher, P., Hope-Stone, L., Damato, B., Heimann, H., Hussain, R., & Cherry, M. G. (2021). Is accurate routine cancer prognostication psychologically harmful? 5-year outcomes of life expectancy prognostication in uveal melanoma survivors. Journal of Cancer Survivorship. doi:10.1007/s11764-021-01036-4
2021
Fear of cancer recurrence and adverse cancer treatment outcomes: predicting 2-to 5-year fear of recurrence from post-treatment symptoms and functional problems in uveal melanoma survivors
Brown, S. L., Fisher, P., Hope-Stone, L., Damato, B., Heimann, H., Hussain, R., & Cherry, M. G. (2021). Fear of cancer recurrence and adverse cancer treatment outcomes: predicting 2-to 5-year fear of recurrence from post-treatment symptoms and functional problems in uveal melanoma survivors. JOURNAL OF CANCER SURVIVORSHIP. doi:10.1007/s11764-021-01129-0
Delivering an NHS Health Psychology service for patients with eye cancer
Hope-Stone, L. (2021). Delivering an NHS Health Psychology service for patients with eye cancer. In Health Psychology in Clinical Practice (pp. 42-59). Routledge. doi:10.4324/9781003120469-4
Prediction of all-cause mortality from 24 month trajectories in patient-reported psychological, clinical and quality of life outcomes in uveal melanoma patients
Brown, S. L., Fisher, P. L., Hope-Stone, L., Heimann, H., Hussain, R., & Cherry, M. G. (2021). Prediction of all-cause mortality from 24 month trajectories in patient-reported psychological, clinical and quality of life outcomes in uveal melanoma patients. Journal of Behavioral Medicine. doi:10.1007/s10865-021-00252-8
2020
Predictors of long-term anxiety and depression in uveal melanoma survivors: A cross-lagged five-year analysis
Brown, S. L., Fisher, P. L., Hope-Stone, L., Hussain, R. N., Heimann, H., Damato, B., & Cherry, M. G. (2020). Predictors of long-term anxiety and depression in uveal melanoma survivors: A cross-lagged five-year analysis. PSYCHO-ONCOLOGY, 29(11), 1864-1873. doi:10.1002/pon.5514
2019
Reflections on a Health Psychology Service for Patients with Uveal Melanoma: The Challenge of Psychological Screening and Intervention When Distress is 'Normal'
Hope-Stone, L., Ablett, J., & Salmon, P. (2019). Reflections on a Health Psychology Service for Patients with Uveal Melanoma: The Challenge of Psychological Screening and Intervention When Distress is 'Normal'. JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS, 26(4), 421-429. doi:10.1007/s10880-018-9595-2
Patient-Reported Outcomes and Quality of Life after Treatment for Choroidal Melanoma
Damato, B., Hope-Stone, L., Cooper, B., Brown, S., Heimann, H., & Dunn, L. (2019). Patient-Reported Outcomes and Quality of Life after Treatment for Choroidal Melanoma. OCULAR ONCOLOGY AND PATHOLOGY, 5(6), 402-411. doi:10.1159/000496927
Comparison between patient-reported outcomes after enucleation and proton beam radiotherapy for uveal melanomas: a 2-year cohort study
Hope-Stone, L., Brown, S. L., Heimann, H., & Damato, B. (2019). Comparison between patient-reported outcomes after enucleation and proton beam radiotherapy for uveal melanomas: a 2-year cohort study. EYE, 33(9), 1478-1484. doi:10.1038/s41433-019-0440-0
2018
Patient-reported Outcomes and Quality of Life After Treatment of Choroidal Melanoma: A Comparison of Enucleation Versus Radiotherapy in 1596 Patients
Damato, B., Hope-Stone, L., Cooper, B., Brown, S. L., Salmon, P., Heimann, H., & Dunn, L. B. (2018). Patient-reported Outcomes and Quality of Life After Treatment of Choroidal Melanoma: A Comparison of Enucleation Versus Radiotherapy in 1596 Patients. AMERICAN JOURNAL OF OPHTHALMOLOGY, 193, 230-251. doi:10.1016/j.ajo.2018.03.015
Predictors of anxiety and depression 2years following treatment in uveal melanoma survivors
Brown, S. L., Hope-Stone, L., Heimann, H., Damato, B., & Salmon, P. (2018). Predictors of anxiety and depression 2years following treatment in uveal melanoma survivors. PSYCHO-ONCOLOGY, 27(7), 1727-1734. doi:10.1002/pon.4715
2016
Two-year patient-reported outcomes following treatment of uveal melanoma
Hope-Stone, L., Brown, S. L., Heimann, H., Damato, B., & Salmon, P. (2016). Two-year patient-reported outcomes following treatment of uveal melanoma. EYE, 30(12), 1598-1605. doi:10.1038/eye.2016.188
2015
How do patients with uveal melanoma experience and manage uncertainty? A qualitative study
Hope-Stone, L., Brown, S. L., Heimann, H., Damato, B., & Salmon, P. (2015). How do patients with uveal melanoma experience and manage uncertainty? A qualitative study. PSYCHO-ONCOLOGY, 24(11), 1485-1491. doi:10.1002/pon.3813
Phantom Eye Syndrome: Patient Experiences after Enucleation for Uveal Melanoma
Hope-Stone, L., Brown, S., & Salmon, P. (2015). Phantom Eye Syndrome: Patient Experiences after Enucleation for Uveal Melanoma. Opthalmology, 122(8), 1585-1590. doi:10.1016/j.ophtha.2015.04.005
2014
Counseling Patients with Cancer
Hope-Stone, L., & Damato, B. (2014). Counseling Patients with Cancer. In Clinical Ophthalmic Oncology (pp. 133-140). Springer Berlin Heidelberg. doi:10.1007/978-3-642-40489-4_14
2012
A nurse-led ocular oncology clinic in Liverpool: results of a 6-month trial
Sandinha, T., Hebbar, G., Kenawy, N., Hope-Stone, L., & Damato, B. (2012). A nurse-led ocular oncology clinic in Liverpool: results of a 6-month trial. EYE, 26(7), 937-943. doi:10.1038/eye.2012.62
2002
A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours.
Francis, R. J., Sharma, S. K., Springer, C., Green, A. J., Hope-Stone, L. D., Sena, L., . . . Begent, R. H. J. (2002). A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours.. British journal of cancer, 87(6), 600-607. doi:10.1038/sj.bjc.6600517
Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study.
Casey, J. L., Napier, M. P., King, D. J., Pedley, R. B., Chaplin, L. C., Weir, N., . . . Begent, R. H. J. (2002). Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study.. British journal of cancer, 86(9), 1401-1410. doi:10.1038/sj.bjc.6600198
2001
Developing empathy to improve patient care: a pilot study of cancer nurses.
Hope-Stone, L. D., & Mills, B. J. (2001). Developing empathy to improve patient care: a pilot study of cancer nurses.. International journal of palliative nursing, 7(3), 146-150. doi:10.12968/ijpn.2001.7.3.8913
1997
The benefits of quality of life measurement in patient care--Part II: A case study.
Hope-Stone, L. D. (1997). The benefits of quality of life measurement in patient care--Part II: A case study.. European journal of cancer care, 6(4), 273-274. doi:10.1046/j.1365-2354.1997.00054.x
The importance of measuring quality of life in phase I/II trials of cancer therapy--the effects of antibody targeted therapy: Part I.
Hope-Stone, L. D., Napier, M. P., Begent, R. H., Cushen, N., & O'Malley, D. (1997). The importance of measuring quality of life in phase I/II trials of cancer therapy--the effects of antibody targeted therapy: Part I.. European journal of cancer care, 6(4), 267-272. doi:10.1046/j.1365-2354.1997.00053.x
1996
Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library.
Begent, R. H., Verhaar, M. J., Chester, K. A., Casey, J. L., Green, A. J., Napier, M. P., . . . Robson, L. (1996). Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library.. Nature medicine, 2(9), 979-984. doi:10.1038/nm0996-979
1994
Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies.
Lane, D. M., Eagle, K. F., Begent, R. H., Hope-Stone, L. D., Green, A. J., Casey, J. L., . . . Glaser, M. G. (1994). Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies.. British journal of cancer, 70(3), 521-525. doi:10.1038/bjc.1994.338